A New Synthetic Toll-Like Receptor 1/2 Ligand is an Efficient Adjuvant for Peptide Vaccination in a Human Volunteer (vol 7, 307, 2019)
Hans-Georg Rammensee,Karl-Heinz Wiesmueller,P. Anoop Chandran,Henning Zelba,Elisa Rusch,Cecile Gouttefangeas,Daniel J. Kowalewski,Moreno Di Marco,Sebastian P. Haen,Juliane S. Walz,Yamel Cardona Gloria,Johanna Boedder, Jill-Marie Schertel,Antje Tunger,Luise Mueller,Maximilian Kiessler,Rebekka Wehner,Marc Schmitz,Markus W. Loeffler,Meike Jakobi,Nicole Schneiderhan-Marra,Reinhild Klein,Karoline Laske,Kerstin Artzner, Linus Backert, Heiko Schuster,Johannes Schwenck,Alexander N. R. Weber,Bernd J. Pichler,Manfred Kneilling,Christian la Fougere,Stephan Forchhammer,Gisela Metzler,Juergen Bauer,Benjamin Weide, Wilfried Schippert,Stefan Stevanovic JOURNAL FOR IMMUNOTHERAPY OF CANCER（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper